Your session is about to expire
← Back to Search
DepCare for Depression (DepCare Trial)
N/A
Recruiting
Led By Nathalie Moise, MD, MS
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months pre-index visit, 4 months post-index visit
Awards & highlights
DepCare Trial Summary
This trial is testing an app to help people with depression get better treatment. The app will help with things like depression screening and education, and aim to improve communication between patients and providers.
Who is the study for?
This trial is for adults with depression, who may also have anxiety, and are getting care in primary clinics. They must speak English or Spanish and score high on specific questionnaires for depression (PHQ-9) and anxiety (GAD-7). People can't join if they've had recent specialized mental health treatment, heart disease, bipolar disorder, dementia, cognitive impairment, pregnancy or psychosis.Check my eligibility
What is being tested?
The study tests a web-app intervention called DepCare against Enhanced Usual Care. The app helps with depression screening and decision-making about treatment options. It aims to see if the tool improves how doctors handle depression care and whether more patients start treatment.See study design
What are the potential side effects?
Since this trial involves a web-application rather than medication, traditional side effects like those seen with drugs aren't expected. However, there could be indirect effects related to changes in patient behavior or decisions regarding their mental health treatments.
DepCare Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months pre-index visit, 4 months post-index visit
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months pre-index visit, 4 months post-index visit
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Total proportion of patients who initiate or optimize depression treatment
Secondary outcome measures
Change in proportion of patients receiving any depression treatment
Mean decisional conflict scale
Mental Depression
+2 moreDepCare Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: DepCare InterventionExperimental Treatment2 Interventions
The clinic (administrators, staff, care managers) will receive quality improvement support and education around depression screening as well as local technical assistance for mental health treatment optimization. The cluster of primary care providers in the intervention arm will receive education and decisional support for optimizing mental health treatment and access to quality improvement/implementation meetings. Eligible patients will receive a tool that facilitates enhanced screening, diagnosis recognition, treatment selection support, psychoeducation, and activation.
Group II: Enhanced Usual CareActive Control1 Intervention
The clinic (administrators, staff, care managers) will receive quality improvement support and education around depression screening as well as local technical assistance for mental health treatment optimization. The cluster of primary care providers and patients in the active comparator arm will have access to this clinic-level strategy (i.e., the same clinic level intervention as in the DepCare group), but will not receive any provider or patient-level interventions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Usual Care
2019
Completed Phase 3
~8530
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,433 Previous Clinical Trials
2,446,993 Total Patients Enrolled
47 Trials studying Depression
37,937 Patients Enrolled for Depression
Agency for Healthcare Research and Quality (AHRQ)FED
399 Previous Clinical Trials
6,822,082 Total Patients Enrolled
17 Trials studying Depression
12,647 Patients Enrolled for Depression
Nathalie Moise, MD, MSPrincipal InvestigatorFlorence Assistant Professor of Medicine
1 Previous Clinical Trials
368 Total Patients Enrolled
1 Trials studying Depression
368 Patients Enrolled for Depression
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have a high score on a depression and anxiety questionnaire (PHQ-9 >= 5 and GAD-7 >= 10).You have a history of heart problems related to your coronary arteries.You are experiencing significant signs of depression.Your score on the Patient Health Questionnaire (PHQ)-9 is 10 or higher, indicating elevated levels of depression symptoms.You have been diagnosed with bipolar disorder.You are pregnant.You have been diagnosed with a mental illness called schizophrenia or psychosis.You have significant memory or thinking problems.
Research Study Groups:
This trial has the following groups:- Group 1: DepCare Intervention
- Group 2: Enhanced Usual Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research initiative in the process of recruiting participants?
"This medical study is still in search of patients, as outlined on clinicaltrials.gov; the research was first posted on August 3rd 2021 and updated last October 7th 2021."
Answered by AI
How many individuals have taken part in this experiment thus far?
"Affirmative. According to clinicaltrials.gov, the trial first advertised on August 3rd 2021 and has been actively recruiting since then; its most recent update came on October 7th 2021. Across one singular site, 266 participants are needed for this experiment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger